Determination of Thujone
Recommendation

19/20 May 2026
All relevant GMP/GACP aspects for Medical Cannabis
Following the previously proposed new European Pharmacopoeia (Ph. Eur.) chapter 2.8.27. Determination of Estragole a second new Ph. Eur. chapter 2.8.28. Determination of Thujone has been published in Pharmeuropa 37.4. Comments on the proposed new text for the "Methods in Pharmacognosy" section of the Ph. Eur. are open until 31 December 2025.
Background
Thujone is found in a number of medicinal plants and their essential oils, such as, common sage, tansy, and wormwood. The substance is considered neurotoxic in high doses. According to a report of EMA's Committee on Herbal Medicinal Products (HMPC) on the use of herbal medicinal products (HMPs) containing thujone, daily thujone intake from medicinal products should be less than 6 mg.
The proposed analytical procedure (gas chromatography) provided in the new Ph. Eur. general chapter 2.8.28. is intended to be used for the quantitative determination of Thujone in herbal drugs and herbal drug preparations. It has been validated for clary sage oil, (cut) sage leaf (Salvia officinalis), three-lobed sage leaf, sage tincture and Spanish sage oil. However, its suitability for other herbal drugs or herbal drug preparations must be demonstrated; otherwise, an alternative validated method must be used.
For more information please go to Pharmeuropa online.
Related GMP News
23.04.2026EMA publishes Draft Guideline on the Declaration of Active Substances in Herbal Drugs
23.04.2026Plans to reclassify Hexahydrocannabinol
02.04.2026What are the GMP Requirements for Medical Cannabis?
02.04.2026EFSA sets Cannabidiol (CBD) Safety Limit
02.04.2026What are the GMP Requirements for Herbal Medicinal Products?
03.03.2026Can Steam Treatment be used to Decontaminate Cannabis?


